Evidence map›Paper›PMID 39279882›Full record

ArticleKidney medicine2024

Protein Intake and High Uric Acid Stone Risk.

Tinika A Montgomery, Hari R Nair, Manali Phadke, Erin Morhardt, Adam Ludvigson, Piruz Motamedinia, Dinesh Singh, Neera K Dahl

Abstract read
In one paragraph

Article in Kidney medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tinika A MontgomerySection of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Hari R NairSection of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Manali PhadkeYale School of Public Health, New Haven, CT.
Erin MorhardtDepartment of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT.
Adam LudvigsonLahey Institute of Urology, Beverely, MA.
Piruz MotamediniaDepartment of Urology, Yale School of Medicine, New Haven, CT.
Dinesh SinghDepartment of Urology, Yale School of Medicine, New Haven, CT.
Neera K DahlDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Rationale & Objective: We evaluated the metabolic differences between pure and impure uric acid stone formers in this retrospective study of uric acid kidney stone formers diagnosed between 1996 and 2021. Study Design: Demographics and medical history were compared by χ Setting & Participants: Patients from Yale Urology and Nephrology Clinics with a documented kidney stone analysis containing uric acid were included. In total, 4,294 kidney stone formers had a stone analysis, and 722 (16.8%) contained uric acid. Patients with all stone analyses Results: Among kidney stone formers, the prevalence of uric acid nephrolithiasis was 16.8%. Pure uric acid stone formers were more likely to be older, heavier, and were 1.5 times more likely to have chronic kidney disease. When controlling for age, sex, race, ethnicity, and body mass index, pure uric acid stone formers had lower urinary pH and lower urine citrate normalized for creatinine. Additionally, they had a higher protein catabolic rate, urine urea nitrogen, and urine sulfur normalized for creatinine, all markers of dietary protein intake. These findings persisted after controlling for chronic kidney disease. Limitations: This is a retrospective study from a single center. Conclusions: Pure uric acid stone formation is more common with diminished kidney function; however, after controlling for kidney function, pure uric acid stone formation is associated with protein intake, suggesting that modifying protein intake may reduce risk.

Indexed as

Chronic kidney diseaseprotein intakeuric acid stones

Identifiers

PMID39279882
PMCPMC11399574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.